Sex-Specific Cell Types and Molecular Pathways Indicate Fibro-Calcific Aortic Valve Stenosis.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2022
Historique:
received: 26 07 2021
accepted: 04 02 2022
entrez: 14 3 2022
pubmed: 15 3 2022
medline: 3 5 2022
Statut: epublish

Résumé

Aortic stenosis (AS) is the most common valve disorder characterized by fibro-calcific remodeling of leaflets. Recent evidence indicated that there is a sex-related difference in AS development and progression. Fibrotic remodeling is peculiar in women's aortic valves, while men's leaflets are more calcified. Our study aimed to assess aortic valve fibrosis (AVF) in a severe AS cohort using non-invasive diagnostic tools and determine whether sex-specific pathological pathways and cell types are associated with severe AS. We have included 28 men and 28 women matched for age with severe AS who underwent echocardiography and cardiac contrast-enhanced computed tomography (CT) before intervention. The calcium and fibrosis volumes were assessed and quantified using the ImageJ thresholding method, indexed calcium and fibrosis volume were calculated by dividing the volume by the aortic annular area. For a deeper understanding of molecular mechanisms characterizing AS disorder, differentially expressed genes and functional inferences between women and men's aortic valves were carried out on a publicly available microarray-based gene expression dataset (GSE102249). Cell types enrichment analysis in stenotic aortic valve tissues was used to reconstruct the sex-specific cellular composition of stenotic aortic valves. In agreement with the literature, our CT quantifications showed that women had significantly lower aortic valve calcium content compared to men, while fibrotic tissue composition was significantly higher in women than men. The expression profiles of human stenotic aortic valves confirm sex-dependent processes. Pro-fibrotic processes were prevalent in women, while pro-inflammatory ones, linked to the immune response system, were enhanced in men. Cell-type enrichment analysis showed that mesenchymal cells were over-represented in AS valves of women, whereas signatures for monocytes, macrophages, T and B cells were enriched men ones. Our data provide the basis that the fibro-calcific process of the aortic valve is sex-specific, both at gene expression and cell type level. The quantification of aortic valve fibrosis by CT could make it possible to perform population-based studies and non-invasive assessment of novel therapies to reduce or halt sex-related calcific aortic valve stenosis (CAVS) progression, acting in an optimal window of opportunity early in the course of the disease.

Sections du résumé

Background
Aortic stenosis (AS) is the most common valve disorder characterized by fibro-calcific remodeling of leaflets. Recent evidence indicated that there is a sex-related difference in AS development and progression. Fibrotic remodeling is peculiar in women's aortic valves, while men's leaflets are more calcified. Our study aimed to assess aortic valve fibrosis (AVF) in a severe AS cohort using non-invasive diagnostic tools and determine whether sex-specific pathological pathways and cell types are associated with severe AS.
Materials and Methods
We have included 28 men and 28 women matched for age with severe AS who underwent echocardiography and cardiac contrast-enhanced computed tomography (CT) before intervention. The calcium and fibrosis volumes were assessed and quantified using the ImageJ thresholding method, indexed calcium and fibrosis volume were calculated by dividing the volume by the aortic annular area. For a deeper understanding of molecular mechanisms characterizing AS disorder, differentially expressed genes and functional inferences between women and men's aortic valves were carried out on a publicly available microarray-based gene expression dataset (GSE102249). Cell types enrichment analysis in stenotic aortic valve tissues was used to reconstruct the sex-specific cellular composition of stenotic aortic valves.
Results
In agreement with the literature, our CT quantifications showed that women had significantly lower aortic valve calcium content compared to men, while fibrotic tissue composition was significantly higher in women than men. The expression profiles of human stenotic aortic valves confirm sex-dependent processes. Pro-fibrotic processes were prevalent in women, while pro-inflammatory ones, linked to the immune response system, were enhanced in men. Cell-type enrichment analysis showed that mesenchymal cells were over-represented in AS valves of women, whereas signatures for monocytes, macrophages, T and B cells were enriched men ones.
Conclusions
Our data provide the basis that the fibro-calcific process of the aortic valve is sex-specific, both at gene expression and cell type level. The quantification of aortic valve fibrosis by CT could make it possible to perform population-based studies and non-invasive assessment of novel therapies to reduce or halt sex-related calcific aortic valve stenosis (CAVS) progression, acting in an optimal window of opportunity early in the course of the disease.

Identifiants

pubmed: 35280999
doi: 10.3389/fimmu.2022.747714
pmc: PMC8907138
doi:

Substances chimiques

Calcium SY7Q814VUP

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

747714

Informations de copyright

Copyright © 2022 Myasoedova, Massaiu, Moschetta, Chiesa, Songia, Valerio, Alfieri, Capoulade, Trabattoni, Andreini, Mass, Parisi and Poggio.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Nat Rev Dis Primers. 2016 Mar 03;2:16006
pubmed: 27188578
Acta Biomater. 2020 Apr 1;106:342-350
pubmed: 32092430
PLoS One. 2012;7(7):e39980
pubmed: 22808080
Arterioscler Thromb Vasc Biol. 2018 Sep;38(9):2148-2159
pubmed: 30026273
J Am Coll Cardiol. 2016 Dec 27;68(25):2733-2744
pubmed: 28007135
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Br J Radiol. 2018 Oct;91(1090):20180196
pubmed: 30004788
Physiology (Bethesda). 2017 May;32(3):182-196
pubmed: 28404735
Circ Cardiovasc Imaging. 2013 Jan 1;6(1):40-7
pubmed: 23233744
Bioinformatics. 2007 Dec 1;23(23):3251-3
pubmed: 17644558
Nat Commun. 2018 Mar 7;9(1):988
pubmed: 29511167
Front Cell Dev Biol. 2020 Jul 10;8:604
pubmed: 32754594
Arterioscler Thromb Vasc Biol. 2020 Jun;40(6):e153-e165
pubmed: 32295422
Am J Physiol Heart Circ Physiol. 2019 Jul 1;317(1):H141-H155
pubmed: 31050556
Int J Mol Sci. 2020 Aug 06;21(16):
pubmed: 32781508
Arterioscler Thromb Vasc Biol. 2020 Dec;40(12):2910-2921
pubmed: 33086873
J Am Coll Cardiol. 2014 Sep 23;64(12):1202-13
pubmed: 25236511
Pharmacol Res. 2018 Oct;136:74-82
pubmed: 30149054
PLoS One. 2010 Nov 15;5(11):e13984
pubmed: 21085593
J Am Coll Cardiol. 2016 May 17;67(19):2263-2288
pubmed: 27049682
Front Cardiovasc Med. 2021 May 10;8:660797
pubmed: 34041283
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
J Am Heart Assoc. 2020 May 18;9(10):e015610
pubmed: 32384012
Circ Res. 2017 Feb 17;120(4):681-691
pubmed: 27879282
Biochim Biophys Acta Mol Basis Dis. 2019 Sep 1;1865(9):2168-2179
pubmed: 31034990
EuroIntervention. 2012 Apr;7(12):1464-9
pubmed: 22522556
Immune Netw. 2016 Feb;16(1):26-32
pubmed: 26937229
Heart. 2021 Dec;107(23):1905-1911
pubmed: 33514522
Eur Heart J Cardiovasc Imaging. 2021 May 10;22(6):626-635
pubmed: 33247903
Compr Physiol. 2017 Jun 18;7(3):799-818
pubmed: 28640443
Circulation. 2018 Jul 24;138(4):377-393
pubmed: 29588317
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Methods Mol Biol. 2020;2120:263-276
pubmed: 32124326

Auteurs

Veronika A Myasoedova (VA)

Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.

Ilaria Massaiu (I)

Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
Developmental Biology of the Immune System, Life and Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.

Donato Moschetta (D)

Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milano, Italy.

Mattia Chiesa (M)

Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
Department of Electronics, Information and Biomedical Engineering, Politecnico di Milano, Milan, Italy.

Paola Songia (P)

Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.

Vincenza Valerio (V)

Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
Dipartimento di Medicina Clinica e Chirurgia, Università degli Studi di Napoli Federico II, Napoli, Italy.

Valentina Alfieri (V)

Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.

Romain Capoulade (R)

L'institut du thorax, INSERM, CNRS, University of Nantes, CHU Nantes, Nantes, France.

Daniela Trabattoni (D)

Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.

Daniele Andreini (D)

Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.
Department of Biomedical and Clinical Sciences "Luigi Sacco", University of Milan, Milan, Italy.

Elvira Mass (E)

Developmental Biology of the Immune System, Life and Medical Sciences (LIMES) Institute, University of Bonn, Bonn, Germany.

Valentina Parisi (V)

Dipartimento di Scienze Mediche traslazionali, Università degli Studi di Napoli Federico II, Napoli, Italy.

Paolo Poggio (P)

Centro Cardiologico Monzino, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH